The safety of SGLT-2 inhibitors in diabetic patients submitted to elective percutaneous coronary intervention regarding kidney function: SAFE-PCI pilot study

Percutaneous coronary intervention (PCI) is one of the most performed well-succeeded therapeutic procedures worldwide, reducing symptoms and improving quality of life. Neutrophil Gelatinase-associated Lipocali...

Source: Diabetology and Metabolic Syndrome - June 26, 2023 Category: Endocrinology Authors: Mateus Paiva Marques Feitosa, Eduardo Gomes Lima, Alexandre Ant ônio Cunha Abizaid, Roxana Mehran, Neuza Helena Moreira Lopes, Thiago de Assis Fischer Ramos, Alexandre Hideo-Kajita, Roberto Kalil Filho and Carlos Vicente Serrano Junior Tags: Research Source Type: research